Found: 256
Select item for more details and to access through your institution.
A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1532, doi. 10.1002/ajh.27364
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1280, doi. 10.1002/ajh.25940
- By:
- Publication type:
- Article
Recognizing "diagnostic futility" ‐ stopping earlier to protect patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 580, doi. 10.1002/ajh.25786
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi‐parametric flow cytometry method.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 424, doi. 10.1002/ajh.25391
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
MASS‐FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. E368, doi. 10.1002/ajh.25244
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Reply to Castillo et al.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. E164, doi. 10.1002/ajh.24765
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 549, doi. 10.1002/ajh.24723
- By:
- Publication type:
- Article
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 435, doi. 10.1002/ajh.24676
- By:
- Publication type:
- Article
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1129, doi. 10.1002/ajh.24532
- By:
- Publication type:
- Article
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 984, doi. 10.1002/ajh.24453
- By:
- Publication type:
- Article
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 585, doi. 10.1002/ajh.24356
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in biclonal gammopathies.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 473, doi. 10.1002/ajh.24319
- By:
- Publication type:
- Article
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 981, doi. 10.1002/ajh.24131
- By:
- Publication type:
- Article
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 888, doi. 10.1002/ajh.24107
- By:
- Publication type:
- Article
Soluble suppression of tumorigenicity 2 (s ST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-pro BNP and troponin T.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 524, doi. 10.1002/ajh.24001
- By:
- Publication type:
- Article
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 181, doi. 10.1002/ajh.23898
- By:
- Publication type:
- Article
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1051, doi. 10.1002/ajh.23827
- By:
- Publication type:
- Article
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 302, doi. 10.1002/ajh.23634
- By:
- Publication type:
- Article
Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 577, doi. 10.1002/ajh.23456
- By:
- Publication type:
- Article
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 5, p. 375, doi. 10.1002/ajh.23413
- By:
- Publication type:
- Article
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 647, doi. 10.1002/ajh.23201
- By:
- Publication type:
- Article
The definition of IgM multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 718, doi. 10.1002/ajh.22080
- By:
- Publication type:
- Article
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 554, doi. 10.1002/ajh.22040
- By:
- Publication type:
- Article
Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 3, p. 251, doi. 10.1002/ajh.21948
- By:
- Publication type:
- Article
IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 853, doi. 10.1002/ajh.21845
- By:
- Publication type:
- Article
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 10, p. 737, doi. 10.1002/ajh.21821
- By:
- Publication type:
- Article
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 10, p. 757, doi. 10.1002/ajh.21822
- By:
- Publication type:
- Article
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
- By:
- Publication type:
- Article
Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 6, p. 431, doi. 10.1002/ajh.21707
- By:
- Publication type:
- Article
Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 3, p. 171, doi. 10.1002/ajh.21603
- By:
- Publication type:
- Article
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 11, p. 840, doi. 10.1002/ajh.21285
- By:
- Publication type:
- Article
Natural history and therapy of 66 patients with mixed cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 7, p. 511, doi. 10.1002/ajh.20643
- By:
- Publication type:
- Article
The Beginner's Guide to Winning the Nobel Prize: A Life in Science.
- Published in:
- 2006
- By:
- Publication type:
- Book Review